Profil bibliographique

Shafagh A. Waters

Informations fournies par OpenAlex. Research Africa ne déduit ni nationalité, ni poste, ni coordonnées personnelles.

92Publications signalées

1541Citations signalées

4Affiliations récentes

Institutions déclarées

UNSW Sydney Sydney Children's Hospital Sydney Children’s Hospitals Network Network Technologies (United States)

Domaines associés

Cystic Fibrosis Research AdvancesNeonatal Respiratory Health ResearchGenetic and Clinical Aspects of Sex Determination and Chromosomal AbnormalitiesTracheal and airway disordersSARS-CoV-2 and COVID-19 Research

Publications récentes

Accès ouvert 2026 articleOpenAlex

Cystic Fibrosis and Colorectal Cancer Risk: Reprogramming of the Intestinal Epithelial Niche and Cell‐State Plasticity in the CFTR Modulator Era

Bala Umashankar, Ines Pankonien, Margarida D. Amaral, Chee Y. Ooi et autres

0 citationsCell Proliferation

Accès ouvert 2026 articleOpenAlex

Predicting clinical efficacy of lung gene delivery in people with cystic fibrosis: which in vitro and in vivo models best predict outcomes in human lungs?

Miftakul Munir, Jeremy Wiyana, Rhiannon B. Werder, Neville J. Butcher et autres

0 citationsExpert Opinion on Drug Delivery

Accès ouvert 2026 articleOpenAlex

Research updates in cystic fibrosis related diabetes: Understanding pathophysiology, expanding animal and human islet models, and advancing clinical and translational research.

Melissa S. Putman, Rebecca L. Hull-Meichle, Shafagh A. Waters, Katherine Tuggle et autres

0 citationsApollo (University of Cambridge)

2026 articleOpenAlex

Research updates in cystic fibrosis related diabetes: Understanding pathophysiology, expanding animal and human islet models, and advancing clinical and translational research

Melissa S. Putman, Rebecca L. Hull-Meichle, Shafagh A. Waters, Katherine L. Tuggle et autres

1 citationJournal of Cystic Fibrosis

Accès ouvert 2026 articleOpenAlex

Building Australia’s non-animal technologies ecosystem: a national cross-sector mapping and strategic insights from the non-animal technologies network (NAT-Net)

Shafagh A. Waters, Adam P. Hill, E.S. Pronker, Gerard E. Kaiko et autres

0 citationsFrontiers in Toxicology

Accès ouvert 2026 preprintOpenAlex

Organoid Guided N-of-1 (ORIGIN-1) Clinical Trial: A phase 4 study to investigate if people with cystic fibrosis with rare non-F508del CFTR mutations with an in-vitro response to Elexacaftor/ Tezacaftor/ Ivacaftor have a clinically meaningful response to Elexacaftor/ Tezacaftor/ Ivacaftor versus placebo.

Lorena Rodrigues Sabino, Gerard E. Kaiko, Douglas J. Dorahy, Thomas Thomas Goodsall et autres

0 citationsResearch Square

Accès ouvert 2025 preprintOpenAlex

Phage-encoded sRNA counteracts xenogenic silencing in pathogenic E. coli

Brandon Sy, Daniel G. Mediati, Michael Payne, Vibhuti Nandel et autres

0 citationsbioRxiv (Cold Spring Harbor Laboratory)

2025 articleOpenAlex

237 Preclinical validation of nasal basal cell grafting as a therapeutic approach to CF sinonasal disease

Do‐Yeon Cho, S. Zhang, Daniel Skinner, Bradford A. Woodworth et autres

0 citationsJournal of Cystic Fibrosis

Accès ouvert 2025 articleOpenAlex

In silico , in vitro and ex vivo characterization of cystic fibrosis transmembrane conductance regulator pathogenic variants localized in the fourth intracellular loop and their rescue by modulators

Emanuela Pesce, Valeria Tomati, Valeria Capurro, Mariateresa Lena et autres

5 citationsBritish Journal of Pharmacology

Accès ouvert 2025 preprintOpenAlex

Gene-Corrected Basal Cells Restore CFTR In Vitro; Transplants Regenerate Epithelium in a Preclinical Sinus Model

Katelin M. Allan, Shaoyan Zhang, Sharon L. Wong, Alexander Capraro et autres

1 citationbioRxiv (Cold Spring Harbor Laboratory)

Accès ouvert 2025 preprintOpenAlex

INTEGRATING GENOMIC AND FUNCTIONAL TESTING TO IMPROVE CFTR MODULATOR RESPONSE PREDICTION IN CHILDREN WITH CYSTIC FIBROSIS

Laura K. Fawcett, Zahra A. Chew, Elena K. Schneider‐Futschik, Katelin M. Allan et autres

0 citationsmedRxiv

Accès ouvert 2025 preprintOpenAlex

Serum Exosomal Multi-Omic Signatures Stratify Glucose Tolerance in Cystic Fibrosis and Reveal Partial Therapeutic Reprogramming by CFTR Modulators

Bala Umashankar, Alexander Capraro, Abhishek Vijayan, Sharon L. Wong et autres

0 citationsmedRxiv

Profil ORCID Notice OpenAlex

BNTIC News n’est pas le producteur de ces données. Recherche à la demande dans Crossref et Europe PMC, sans clé ; OpenAlex reste optionnel. Aucun service payant requis, aucune réponse conservée. Sources et limites.